We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $91.9M
1-Year Est. Return 27.41%
This Fund
S&P 500
This Quarter Est. Return
+5.26%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$24B
AUM Growth
+$1.05B
Cap. Flow
-$221M
Cap. Flow %
-0.92%
Top 10 Hldgs %
13.73%
Holding
1,494
New
103
Increased
612
Reduced
406
Closed
115

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$114M
2
AET
Aetna Inc
AET
+$96.3M
3
TRV icon
Travelers Companies
TRV
+$94.5M
4
CHK
Chesapeake Energy Corporation
CHK
+$89M
5
AEE icon
Ameren
AEE
+$69.4M

Top Sells

Rank Stock Value
1
DB icon
Deutsche Bank
DB
+$247M
2
VZ icon
Verizon
VZ
+$186M
3
MDT icon
Medtronic
MDT
+$150M
4
LO
LORILLARD INC COM STK
LO
+$126M
5
JCI icon
Johnson Controls International
JCI
+$104M

Sector Composition

Rank Sector Weight
1 Healthcare 15.44%
2 Technology 14.68%
3 Financials 12.75%
4 Industrials 11.1%
5 Energy 9.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
F icon
226
Ford
F
$53.8B
$23.7M 0.1%
1,377,131
-563,319
-29% -$9.16M
CMS icon
227
CMS Energy
CMS
$20.7B
$23.5M 0.1%
754,976
+629,314
+501% +$18.7M
CPHD
228
DELISTED
Cepheid Inc
CPHD
$23.5M 0.1%
489,486
+31,799
+7% +$1.44M
AGN
229
DELISTED
Allergan Inc
AGN
$23.4M 0.1%
138,330
-25,334
-15% -$3.94M
EBAY icon
230
eBay
EBAY
$48.1B
$23.2M 0.1%
1,102,428
-105,606
-9% -$2.3M
STJ
231
DELISTED
St Jude Medical
STJ
$23.1M 0.1%
332,961
-47,735
-13% -$3.09M
SLXP
232
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
$22.8M 0.09%
184,849
-31,986
-15% -$3.54M
TSM icon
233
TSMC
TSM
$2.15T
$22.7M 0.09%
1,062,376
-11,078
-1% -$228K
GIS icon
234
General Mills
GIS
$19.6B
$22.6M 0.09%
430,523
+26,886
+7% +$1.43M
MRSH
235
Marsh
MRSH
$85.8B
$22.6M 0.09%
436,500
+63,000
+17% +$3.13M
INCY icon
236
Incyte
INCY
$24.7B
$22.6M 0.09%
400,703
+21,217
+6% +$1.08M
AFL icon
237
Aflac
AFL
$58.9B
$22.5M 0.09%
723,600
+630,200
+675% +$19.7M
ZBH icon
238
Zimmer Biomet
ZBH
$18.8B
$22.5M 0.09%
223,206
+9,373
+4% +$915K
CAVM
239
DELISTED
Cavium, Inc.
CAVM
$22.5M 0.09%
452,521
-166,241
-27% -$7.65M
IWB icon
240
iShares Russell 1000 ETF
IWB
$48.4B
$22.4M 0.09%
203,855
+1,500
+0.7% +$160K
GNW icon
241
Genworth Financial
GNW
$3.78B
$22.3M 0.09%
1,278,850
+803,290
+169% +$14M
MHK icon
242
Mohawk Industries
MHK
$8.74B
$22M 0.09%
158,960
-250,629
-61% -$33.9M
VTV icon
243
Vanguard Morningstar Value ETF
VTV
$190B
$21.9M 0.09%
270,101
+119,900
+80% +$9.49M
JAZZ icon
244
Jazz Pharmaceuticals
JAZZ
$15.6B
$21.7M 0.09%
147,354
-2,642
-2% -$366K
PII icon
245
Polaris
PII
$3.29B
$21.6M 0.09%
166,221
+21,382
+15% +$2.83M
TWX
246
DELISTED
Time Warner Inc
TWX
$21.6M 0.09%
308,115
-469,055
-60% -$30.8M
KMB icon
247
Kimberly-Clark
KMB
$32.8B
$21.5M 0.09%
201,736
+44,470
+28% +$4.73M
VIAB
248
DELISTED
Viacom Inc. Class B
VIAB
$21.3M 0.09%
245,392
-78,345
-24% -$6.66M
HES
249
DELISTED
Hess
HES
$21.2M 0.09%
214,618
-240,332
-53% -$21.7M
SYK icon
250
Stryker
SYK
$108B
$21.2M 0.09%
251,128
+28,148
+13% +$2.3M
8 9
10
11 12

Similar funds

VI
Ventas Inc Chicago, Illinois $91.9M AUM 27.96% 1-Year Est. Return
FA
Forefront Analytics West Conshohocken, Pennsylvania $92M AUM 25.18% 1-Year Est. Return
PBCM
Point Break Capital Management Miami, Florida $91.7M AUM
CCAM
Crystal Cove Asset Management Newport Beach, California $91.7M AUM
GBA
Garrison Bradford & Associates New York $92.2M AUM 19.08% 1-Year Est. Return
AWP
Atlas Wealth Partners Wyomissing, Pennsylvania $91.6M AUM 9.52% 1-Year Est. Return
HI
Hyundai Investments Yeongdeungopo-Gu, Seoul, South Korea $92.3M AUM 0.12% 1-Year Est. Return
DCA
DB&C Advisors Holland, Michigan $92.4M AUM

Axa's Q2 2014 Portfolio in Review

As of Q2 2014, Axa held 1,494 positions worth $24B, up 4.6% from $23B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Axa's Q2 2014 filing shows 103 new, 612 increased, 406 reduced and 115 closed positions. Its largest new stake was Boston Scientific: 4,394,250 shares worth $56.1M. The largest sale was Deutsche Bank, an estimated $247M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 16% a quarter earlier, followed by Technology and Financials.

  • Axa's largest Q2 2014 buy was Boston Scientific: 4,394,250 shares worth $56.1M.
  • Axa added most to Gilead Sciences in Q2 2014, an estimated $114M increase.
  • Axa's biggest Q2 2014 reduction was Deutsche Bank, cutting an estimated $247M.
  • Axa fully exited OMNICARE INC in Q2 2014, selling an estimated $20.4M.
  • Axa's ten largest holdings make up 14% of its $24B portfolio in Q2 2014.
  • Axa opened 103 new positions and closed 115 in Q2 2014.
  • Axa's portfolio value rose 4.6% quarter-over-quarter to $24B.

Based on Axa's 13F filing for Q2 2014, filed 13 Aug 2014.